Xiaojuan Lin

2PUBLICATIONS
2CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jul 10, 2026
Forty-month durable partial response with well-tolerated olaparib maintenance in a 92-year-old patient with BRCA2-mutated uterine serous carcinoma: a case report.

|Jun 22, 2026
KPNA2 Drives Immunosuppression in Ovarian Cancer via CCL2/CCR2-Dependent MDSC Recruitment.

Pageof 1

Frequent Collaborators

1 joint publications

Ce Bian

1 joint publications

Qingli Li